Home » Topics » Regulatory » EMA

EMA
RSS

EMA confirms design of Intercell's planned phase II/III trial of Pseudomonas aeruginosa vaccine

Oct. 13, 2011

No Comments

EMA recommends new orphan designation for 4SC-201

Oct. 13, 2011

No Comments

EMA accepts MAA for IB-1001

Oct. 4, 2011

No Comments

Aegerion gives update on European filing for lomitapide

Sep. 30, 2011

No Comments

CHMP recommends approval of Prevanar 13 for new indication

Sep. 28, 2011

No Comments

CHMP issues opinion on new indication for Avastin

Sep. 28, 2011

No Comments

CHMP recommends approval of Alimta for new indication

Sep. 27, 2011

No Comments

FDA approves new indication for Soliris

Sep. 27, 2011

No Comments

Kombiglyze recommended for approval in E.U.

Sep. 27, 2011

No Comments

European approval recommended for Levemir as add-on to Victoza

Sep. 27, 2011

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

EMA
RSS

EMA confirms design of Intercell's planned phase II/III trial of Pseudomonas aeruginosa vaccine

EMA recommends new orphan designation for 4SC-201

EMA accepts MAA for IB-1001

Aegerion gives update on European filing for lomitapide

CHMP recommends approval of Prevanar 13 for new indication

CHMP issues opinion on new indication for Avastin

CHMP recommends approval of Alimta for new indication

FDA approves new indication for Soliris

Kombiglyze recommended for approval in E.U.

European approval recommended for Levemir as add-on to Victoza

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

Phase III AMD miss leaves BLA Outlook same with bevacizumab

EMA RSS

EMA
RSS